Ducky Sherwood:: oral minocycline significantly helped 89% of long COVID patients 2024-12-07 General – Pandemics in British Columbia
Discovered: Dec 11, 2024 23:55 Ducky Sherwood:: oral minocycline significantly helped 89% of long COVID patients 2024-12-07 General – Pandemics in British Columbia <– QUOTE: ⭐ ❗❗This paper from Japan (2024-12-02) reported that oral minocycline significantly helped 89% of long COVID patients in what was effectively a big case study, especially when given in the first six months. There was improvement in fatigue, post-exertional malaise, unrefreshing sleep, brain fog, disequilibrium, orthostatic intolerance, and neuropathic pain. (Minocycline is an antibiotic, but also has a number of protective effects on neurons.) <- Read the whole thing! Need more studies!
Caveats again quoting Ducky
Oral minocycline does frequently give unpleasant levels of nausea and/or dizziness, so it’s not an ideal medicine. Also please note that
- Not everyone was helped;
- People who had ME/CFS for longer were helped less;
- This was not a randomized trial — there was no control group, so partly this might be placebo effect.
- These weren’t the sickest Long COVID patients: people had to be able to stand and walk (and, it appears, to come to a hospital) in order to participate in the study.
- Most of the improvement was in people who had Long COVID for less than six months, so maybe they would have recovered on their own. However, it is encouraging news!